应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02171 科济药业-B
未开盘 02-02 16:08:06
14.410
-1.090
-7.03%
最高
15.520
最低
14.300
成交量
241.80万
今开
15.520
昨收
15.500
日振幅
7.87%
总市值
82.14亿
流通市值
82.14亿
总股本
5.70亿
成交额
3,524万
换手率
0.42%
流通股本
5.70亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 科济药业-B 01月27日卖空量成交5.2万股,卖空比例为3.52%
市场透视 · 01-27
每日卖空追踪 | 科济药业-B 01月27日卖空量成交5.2万股,卖空比例为3.52%
科济药业-B(02171)发盈警 预期2025年取得净亏损同比减少至不超过约1.2亿元
智通财经 · 01-26
科济药业-B(02171)发盈警 预期2025年取得净亏损同比减少至不超过约1.2亿元
科济药业-B财年亏损收窄:泽沃基奥仑赛等产品收入增长驱动业绩改善
美股速递 · 01-26
科济药业-B财年亏损收窄:泽沃基奥仑赛等产品收入增长驱动业绩改善
每日卖空追踪 | 科济药业-B 01月26日卖空量成交5.65万股,卖空比例为5.51%
市场透视 · 01-26
每日卖空追踪 | 科济药业-B 01月26日卖空量成交5.65万股,卖空比例为5.51%
科济药业-B盘中异动 股价大跌5.12%
市场透视 · 01-26
科济药业-B盘中异动 股价大跌5.12%
科濟藥業(02171)更新翌日披露報表,回购24.5万股股份,总额约404.7万港元
公告速递 · 01-23
科濟藥業(02171)更新翌日披露報表,回购24.5万股股份,总额约404.7万港元
科济药业-B01月23日获主力加仓481.1万元
市场透视 · 01-23
科济药业-B01月23日获主力加仓481.1万元
科济药业-B午前涨超4% 近日宣布与Dispatch Bio达成合作
新浪港股 · 01-22
科济药业-B午前涨超4% 近日宣布与Dispatch Bio达成合作
每日卖空追踪 | 科济药业-B 01月20日卖空量成交2.5万股,卖空比例为2.97%
市场透视 · 01-20
每日卖空追踪 | 科济药业-B 01月20日卖空量成交2.5万股,卖空比例为2.97%
科济药业-B01月20日遭主力抛售420.3万元
市场透视 · 01-20
科济药业-B01月20日遭主力抛售420.3万元
每日卖空追踪 | 科济药业-B 01月19日卖空量成交10.55万股,卖空比例为11%
市场透视 · 01-19
每日卖空追踪 | 科济药业-B 01月19日卖空量成交10.55万股,卖空比例为11%
每日卖空追踪 | 科济药业-B 01月16日卖空量成交3.9万股,卖空比例为2.79%
市场透视 · 01-16
每日卖空追踪 | 科济药业-B 01月16日卖空量成交3.9万股,卖空比例为2.79%
每日卖空追踪 | 科济药业-B 01月14日卖空量成交3.5万股,卖空比例为2.33%
市场透视 · 01-14
每日卖空追踪 | 科济药业-B 01月14日卖空量成交3.5万股,卖空比例为2.33%
科济药业-B01月14日遭主力抛售150.2万元
市场透视 · 01-14
科济药业-B01月14日遭主力抛售150.2万元
科济药业-B达成临床合作 计划2026年在华启动I期试验
美股速递 · 01-12
科济药业-B达成临床合作 计划2026年在华启动I期试验
科济药业与Dispatch Bio达成临床合作,评估Flare平台及Zevor-Cel在实体瘤中的应用
美股速递 · 01-12
科济药业与Dispatch Bio达成临床合作,评估Flare平台及Zevor-Cel在实体瘤中的应用
科济药业与Dispatch Bio宣布达成临床合作,探索Flare平台与赛恺泽®在实体瘤中的应用
美通社 · 01-12
科济药业与Dispatch Bio宣布达成临床合作,探索Flare平台与赛恺泽®在实体瘤中的应用
每日卖空追踪 | 科济药业-B 01月12日卖空量成交4.25万股,卖空比例为4.2%
市场透视 · 01-12
每日卖空追踪 | 科济药业-B 01月12日卖空量成交4.25万股,卖空比例为4.2%
每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%
市场透视 · 01-08
每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%
科济药业-B01月08日主力净流出397.3万元 散户资金买入
市场透视 · 01-08
科济药业-B01月08日主力净流出397.3万元 散户资金买入
加载更多
公司概况
公司名称:
科济药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在中国和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":14.41,"timestamp":1770019686002,"preClose":15.5,"halted":0,"volume":2418000,"delay":0,"changeRate":-0.07032258064516128,"floatShares":570000000,"shares":570000000,"eps":-1.443602,"marketStatus":"未开盘","change":-1.09,"latestTime":"02-02 16:08:06","open":15.52,"high":15.52,"low":14.3,"amount":35240930,"amplitude":0.07871,"askPrice":14.43,"askSize":2500,"bidPrice":14.4,"bidSize":174000,"shortable":3,"etf":0,"ttmEps":-1.040003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":0,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.5,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":2.3666438289589244,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"2606759228","title":"每日卖空追踪 | 科济药业-B 01月27日卖空量成交5.2万股,卖空比例为3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606759228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606759228?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502630,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月27日,涨1.52%,卖空量成交5.2万股,较上一交易日减少56.3%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164011a6b236b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164011a6b236b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1585","02171","BK1574","BK1587"],"gpt_icon":0},{"id":"2606213499","title":"科济药业-B(02171)发盈警 预期2025年取得净亏损同比减少至不超过约1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606213499","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606213499?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:09","pubTimestamp":1769418565,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B 发布公告,根据对本集团截至2025年12月31日止年度的最新未经审核管理账目的初步评估及董事会目前可得的资料,基于以下一系列因素,包括泽沃基奥仑赛注射液的商业化及舒瑞基奥仑赛注射液的新药申请获国家药品监督管理局接纳,预计本集团将出现净亏损和经调整净亏损同比减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"1196692680","title":"科济药业-B财年亏损收窄:泽沃基奥仑赛等产品收入增长驱动业绩改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1196692680","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196692680?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:05","pubTimestamp":1769418317,"startTime":"0","endTime":"0","summary":"科济药业-B在最新财年实现亏损幅度显著收窄,主要得益于核心产品泽沃基奥仑赛(Zevorcabtagene Autoleucel)及其他业务板块收入的持续提升。财报数据显示,公司通过优化商业化布局与扩大市场覆盖,有效推动了营收结构的改善。随着CAR-T疗法市场需求的逐步释放,科济药业在研发转化与商业化协同方面展现出强劲动能,为未来盈利能力的进一步修复奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"2606222600","title":"每日卖空追踪 | 科济药业-B 01月26日卖空量成交5.65万股,卖空比例为5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606222600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606222600?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416228,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月26日,跌3.66%,卖空量成交5.65万股,较上一交易日减少56.7%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164015a456c876&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164015a456c876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1587","BK1574","02171","BK1161"],"gpt_icon":0},{"id":"2606609222","title":"科济药业-B盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606609222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606609222?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:03","pubTimestamp":1769410986,"startTime":"0","endTime":"0","summary":"2026年01月26日下午盘15时03分,科济药业-B股票出现波动,股价大幅跳水5.12%。截至发稿,该股报15.560港元/股,成交量73.3万股,换手率0.13%,振幅5.61%。科济药业-B股票所在的生物技术行业中,整体跌幅为2.19%。科济药业-B公司简介:科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126150306a6ad0c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126150306a6ad0c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1585","02171","BK1574"],"gpt_icon":0},{"id":"1194545107","title":"科濟藥業(02171)更新翌日披露報表,回购24.5万股股份,总额约404.7万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194545107","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194545107?lang=zh_cn&edition=full","pubTime":"2026-01-23 21:05","pubTimestamp":1769173547,"startTime":"0","endTime":"0","summary":"科濟藥業控股有限公司于2026年1月23日发布翌日披露报表,就2025年11月11日的股份回购事宜进行更新。根据公告,公司当日按每股平均价格约港币16.5193元回购普通股24.5万股,涉资约港币404.724万。该回购股份占当时已发行股本约0.043%。科濟藥業同时声明,本次股份回购符合香港联合交易所有限公司证券上市规则及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"2605287914","title":"科济药业-B01月23日获主力加仓481.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605287914","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605287914?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:16","pubTimestamp":1769156163,"startTime":"0","endTime":"0","summary":"01月23日, 科济药业-B股价涨3.34%,报收16.40元,成交金额1828.2万元,换手率0.20%,振幅4.73%,量比1.12。科济药业-B今日主力资金净流入481.1万元,上一交易日主力净流入47.0万元。该股近5个交易日上涨1.48%,主力资金累计净流入8.4万元;近20日主力资金累计净流出990.5万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162535a6a43c61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162535a6a43c61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0},{"id":"2605459543","title":"科济药业-B午前涨超4% 近日宣布与Dispatch Bio达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2605459543","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605459543?lang=zh_cn&edition=full","pubTime":"2026-01-22 11:50","pubTimestamp":1769053800,"startTime":"0","endTime":"0","summary":" 科济药业-B午前股价上涨4.22%,现报16.31港元,成交额730.22万港元。 近日,据科技药业官微消息,公司宣布,与Dispatch Bio达成临床合作,计划于2026年在中国启动一项I期临床试验。该试验将评估联合疗法DISP-11在实体瘤患者的中的应用。 据介绍,该联合疗法由Dispatch公司首创Flare平台开发的在研疗法与科济药业的靶向BCMA自体CAR-T细胞产品赛恺泽联用组成。赛恺泽已获得中国国家药品监督管理局批准用于治疗多发性骨髓瘤。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-01-22/doc-inhicwux4813098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0},{"id":"2604700195","title":"每日卖空追踪 | 科济药业-B 01月20日卖空量成交2.5万股,卖空比例为2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604700195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604700195?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897828,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月20日,跌3.25%,卖空量成交2.5万股,较上一交易日减少91.88%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165234a72fcde0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165234a72fcde0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"2604195773","title":"科济药业-B01月20日遭主力抛售420.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195773","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604195773?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:16","pubTimestamp":1768896966,"startTime":"0","endTime":"0","summary":"01月20日, 科济药业-B股价跌3.25%,报收15.48元,成交金额1307.0万元,换手率0.15%,振幅3.88%,量比0.65。科济药业-B今日主力资金净流出420.3万元,上一交易日主力净流出8.7万元。该股近5个交易日下跌5.93%,主力资金累计净流出470.5万元;近20日主力资金累计净流出716.3万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120163253a44037d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120163253a44037d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1574","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"2604316099","title":"每日卖空追踪 | 科济药业-B 01月19日卖空量成交10.55万股,卖空比例为11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604316099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604316099?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811427,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月19日,跌1.17%,卖空量成交10.55万股,较上一交易日增加6.03%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164123a43c267a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164123a43c267a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1587","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2604234943","title":"每日卖空追踪 | 科济药业-B 01月16日卖空量成交3.9万股,卖空比例为2.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604234943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604234943?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:30","pubTimestamp":1768552227,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月16日,跌1.22%,卖空量成交3.9万股,较上一交易日减少60.61%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116163905a4cb3a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116163905a4cb3a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02171","BK1574","BK1587","BK1585"],"gpt_icon":0},{"id":"2603935627","title":"每日卖空追踪 | 科济药业-B 01月14日卖空量成交3.5万股,卖空比例为2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603935627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603935627?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:30","pubTimestamp":1768379427,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月14日,跌1.77%,卖空量成交3.5万股,较上一交易日减少58.58%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164141a7196923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164141a7196923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02171","BK1585","BK1161"],"gpt_icon":0},{"id":"2603962762","title":"科济药业-B01月14日遭主力抛售150.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603962762","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603962762?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378550,"startTime":"0","endTime":"0","summary":"01月14日, 科济药业-B股价跌1.77%,报收16.06元,成交金额2412.3万元,换手率0.26%,振幅6.48%,量比1.10。科济药业-B今日主力资金净流出150.2万元,上一交易日主力净流出367.8万元。该股近5个交易日下跌2.96%,主力资金累计净流出1186.1万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入265.6万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162124a4c25902&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162124a4c25902&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1574","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"1119668709","title":"科济药业-B达成临床合作 计划2026年在华启动I期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1119668709","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119668709?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:08","pubTimestamp":1768223289,"startTime":"0","endTime":"0","summary":"科济药业-B(CARsgen Therapeutics Holdings Ltd)宣布达成一项临床合作协议,将在中国开展I期临床试验。该试验计划于2026年启动,标志着公司在肿瘤免疫治疗领域的重要布局。此次合作旨在评估新型细胞治疗产品的安全性和初步疗效,为后续临床开发奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1161","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"1101397235","title":"科济药业与Dispatch Bio达成临床合作,评估Flare平台及Zevor-Cel在实体瘤中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1101397235","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101397235?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:06","pubTimestamp":1768223179,"startTime":"0","endTime":"0","summary":"科济药业与Dispatch Bio Therapeutics近日共同宣布,双方已签署临床合作协议,将重点评估基于Dispatch Bio专有Flare技术平台开发的Zevor-Cel在实体瘤治疗领域的潜力。这项合作旨在探索该创新CAR-T疗法针对多种实体瘤的临床效果与安全性。Flare平台以其高效靶向递送机制著称,有望提升CAR-T疗法在实体瘤微环境中的渗透性与持久性。Zevor-Cel作为靶向Claudin18.2的CAR-T产品,此前已在胃癌、胰腺癌等实体瘤中展现出初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"2602754578","title":"科济药业与Dispatch Bio宣布达成临床合作,探索Flare平台与赛恺泽®在实体瘤中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2602754578","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602754578?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":"科济药业与Dispatch Bio达成临床合作 该试验将评估联合疗法DISP-11在实体瘤患者的中的应用。Dispatch的Flare平台为我们提供了一种差异化且高度互补的策略,有望进一步拓宽CAR-T疗法的应用场景,尤其是缺少特异性靶点的实体肿瘤。关于Dispatch的Flare平台 由于实体瘤缺乏肿瘤特异性靶点及存在免疫抑制微环境,免疫疗法在实体瘤领域的应用有限。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4860752_ZH60752_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","02171","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"2602546443","title":"每日卖空追踪 | 科济药业-B 01月12日卖空量成交4.25万股,卖空比例为4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602546443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602546443?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206626,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月12日,跌2.19%,卖空量成交4.25万股,较上一交易日减少29.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164831a710c8d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164831a710c8d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02171","BK1574","BK1585"],"gpt_icon":0},{"id":"2602840340","title":"每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602840340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602840340?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861029,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月08日,跌1.15%,卖空量成交4.5万股,较上一交易日减少65.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164710a7023cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164710a7023cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"2602347002","title":"科济药业-B01月08日主力净流出397.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602347002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602347002?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:16","pubTimestamp":1767860167,"startTime":"0","endTime":"0","summary":"01月08日, 科济药业-B股价跌1.15%,报收16.38元,成交金额2688.0万元,换手率0.28%,振幅3.74%,量比1.16。科济药业-B今日主力资金净流出397.3万元,上一交易日主力净流出0万元。该股近5个交易日上涨11.78%,主力资金累计净流出494.4万元;近20日主力资金累计净流入1195.4万元,其中净流入天数为11日。该股主力净额占比0.04%,港股市场排名2578/2713。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108163136a4ab34ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108163136a4ab34ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":-0.088},{"period":"1month","weight":-0.0594},{"period":"3month","weight":-0.1366},{"period":"6month","weight":-0.3171},{"period":"1year","weight":0.4296},{"period":"ytd","weight":-0.0296}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0317},{"period":"6month","weight":0.0749},{"period":"1year","weight":0.3239},{"period":"ytd","weight":0.0447}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在中国和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07858},{"month":2,"riseRate":0.6,"avgChangeRate":0.233977},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}